The NYT had an interesting piece this morning on how insurers are trying to reduce the cost of treating cancer. While the piece notes that much of the cost is related to the high price of new cancer drugs it would have been worth mentioning that this is the result of government granted patent monopolies. If the government used a different mechanism for financing drug development and allowed drugs to be sold at the free market price, all of these treatments would be relatively low cost. The doctors would be able to choose the one that they viewed as best for their patient without worrying about the cost.

Leave your comments

Post comment as a guest

0
  • No comments found

GuideStar Exchange Gold charity navigator LERA cfc IFPTE

contact us

1611 Connecticut Ave., NW
Suite 400
Washington, DC 20009
(202) 293-5380
info@cepr.net

let's talk about it

Follow us on Twitter Like us on Facebook Follow us on Tumbler Connect with us on Linkedin Watch us on YouTube Google+ feed cepr.net rss feed